[1]
2018. Cabozantinib for the Management of Metastatic Clear Cell Renal Cell Carcinoma. Journal of Kidney Cancer and VHL. 5, 4 (Oct. 2018), 1–5. DOI:https://doi.org/10.15586/jkcvhl.2018.109.